Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3458]

FDA approves venetoclax for chronic lymphocytic leukaemia and small lymphocytic lymphoma

FDA approves venetoclax for chronic lymphocytic leukaemia and small lymphocytic lymphoma

Proton therapy for cancer lowers risk of side effects

Proton therapy for cancer lowers risk of side effects

Children with cancer wait an average of 6.5 years longer than adults to access new drugs

Children with cancer wait an average of 6.5 years longer than adults to access new drugs

Stem cell differences could explain why women are more likely to develop adrenal cancer

Stem cell differences could explain why women are more likely to develop adrenal cancer

Using 3D to test personalised treatments in five days

Using 3D to test personalised treatments in five days

$Soy foods linked to fewer fractures in younger breast cancer survivors$

Soy foods linked to fewer fractures in younger breast cancer survivors

Experts urge stronger emphasis on cancer prevention in older population

Experts urge stronger emphasis on cancer prevention in older population

Rare pulmonary side effects of brigatinib often resolve without treatment discontinuation

Rare pulmonary side effects of brigatinib often resolve without treatment discontinuation

Partial breast irradiation effective treatment option for low-risk breast cancer

Partial breast irradiation effective treatment option for low-risk breast cancer

Enzyme PHLPP2 could be a viable drug target for treating prostate cancer

Enzyme PHLPP2 could be a viable drug target for treating prostate cancer

More from ecancer